Showing results (11-20 of 126) with videos related to

Sort By:
Pageof 13
Physics in Medicine and Biology|July 7, 2018
Dynamic 18F-FLT PET imaging of spatiotemporal changes in tumor cell proliferation and vasculature reveals the mechanistic actions of anti-angiogenic therapyMatthew Scarpelli, Urban Simoncic, Scott Perlman, et al.
Clinical Genitourinary Cancer|March 6, 2012
Phase II trial of weekly ixabepilone in men with metastatic castrate-resistant prostate cancer (E3803): a trial of the Eastern Cooperative Oncology GroupGlenn Liu, Yu-Hui Chen, Robert Dipaola, et al.
Clinical Advances in Hematology & Oncology : H&O|December 29, 2012
Current controversies in the management of biochemical failure in prostate cancerJustine Yang Bruce, Joshua M Lang, Douglas G McNeel, et al.
Urologic Oncology|March 14, 2013
High resolution ultrasound features of prostatic rib metastasis: a prospective feasibility study with implication in the high-risk prostate cancer patientKenneth S Lee, Arthur A De Smet, Glenn Liu, et al.
Journal for Immunotherapy of Cancer|February 1, 2019
FLT PET/CT imaging of metastatic prostate cancer patients treated with pTVG-HP DNA vaccine and pembrolizumabMatthew Scarpelli, Christopher Zahm, Scott Perlman, et al.
Investigational New Drugs|September 19, 2009
A phase I study of zibotentan (ZD4054) in patients with metastatic, castrate-resistant prostate cancerWilliam R Schelman, Glenn Liu, George Wilding, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 16, 2009
An open-label, multicenter, phase I/II study of single-agent AT-101 in men with castrate-resistant prostate cancerGlenn Liu, W Kevin Kelly, George Wilding, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 5, 2011
In vivo near-infrared fluorescence imaging of CD105 expression during tumor angiogenesisYunan Yang, Yin Zhang, Hao Hong, et al.
American Journal of Clinical Oncology|December 1, 2005
Phase I study of piritrexim and gemcitabine in patients with advanced solid tumorsMichael Huie, Michael Carducci, Glenn Liu, et al.
Clinical Genitourinary Cancer|August 17, 2014
Comparison of NaF and FDG PET/CT for assessment of treatment response in castration-resistant prostate cancers with osseous metastasesUrban Simoncic, Scott Perlman, Glenn Liu, et al.
Pageof 13